TrialBlood2014

Long-term outcome with dasatinib after imatinib failure in chronic-phase chronic myeloid leukemia: follow-up of a phase 3 study.

Neil P Shah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.